Vol. 4 No. 12 (2024) | Canadian Journal of Health Technologies

Peer-Reviewed Article

Canadian Trends in Estimated Drug Purchases and Projections: 2024 and 2025

Mina Tadrous, Kevin Z. Wang, Shanzeh Chaudhry, Cherry Chu, Fiona Clement, Jason R. Guertin, Michael R. Law, Wade Thompson, Tara Gomes, Kaleen N. Hayes

Published December 18, 2024

PDF HTML

Reimbursement Recommendations

Enfortumab Vedotin (Padcev)

CDA-AMC

Published December 17, 2024

PDF HTML

Venetoclax (Venclexta)

CDA-AMC

Published December 16, 2024

PDF HTML

Lisocabtagene Maraleucel (Breyanzi)

CDA-AMC

Published December 13, 2024

PDF HTML

Fruquintinib (Fruzaqla)

CDA-AMC

Published December 13, 2024

PDF HTML

Health Technology Review Recommendation

RapidAI for Stroke Detection

CDA-AMC

Published December 5, 2024

PDF HTML

Reimbursement Reviews

Inclisiran (Leqvio)

CDA-AMC

Published December 19, 2024

PDF HTML

Brentuximab Vedotin (Adcetris)

CDA-AMC

Published December 16, 2024

PDF HTML

Atogepant (Qulipta)

CDA-AMC

Published December 13, 2024

PDF HTML

Evolocumab (Repatha)

CDA-AMC

Published December 11, 2024

PDF HTML

Etrasimod (Velsipity)

CDA-AMC

Published December 3, 2024

PDF HTML

Health Technology Reviews

Optimizing Hospital Diagnostic Ultrasound Scheduling: A Brief Survey

CDA-AMC

Published December 12, 2024

PDF HTML

Health System Readiness for Disease-Modifying Therapies for Alzheimer Disease

CDA-AMC

Published December 4, 2024

PDF HTML

Artificial Intelligence–Assisted Colonoscopy for Detecting Polyps, Adenomas, Precancerous Lesions, and Colorectal Cancer

CDA-AMC

Published December 2, 2024

PDF HTML

Horizon Scans

Emerging Antiviral Drugs to Prevent or Treat Influenza

CDA-AMC

Published December 13, 2024

PDF HTML

##issue.tableOfContents##

Table of Contents

Peer-Reviewed Article

Reimbursement Recommendations

Health Technology Review Recommendation

Reimbursement Reviews

Health Technology Reviews

Horizon Scans